Opportunities for cell and gene therapy landscape remain high but so does challenges: GlobalData
There are 694 CGTs in development across various therapy areas in the US as of February 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
chronic diseases
India is a key market for the company’s global plans
Vikrant Shrotriya, CVP & MD, Novo Nordisk India in an interaction with Express Pharma growth opportunities in pharma sector…